Nov 19, 2020
STAMFORD, Conn., November 19, 2020 — Alliance for Cancer Cell and Gene Therapy (ACGT) announces that Michael T. Lotze, MD, immunologist at UPMC Hillman Cancer Center and professor of surgery, immunology and bioengineering at the University of Pittsburgh School of Medicine. has been named chair of the prestigious ACGT Scientific Advisory Council.
Read MoreOct 06, 2020
Versatile and Highly Scalable Technology Simultaneously Targets Multiple Differences and Activates Multiple Immune System Responses
STAMFORD, Conn. — With a $500,000 Research Grant from Alliance for Cancer Gene Therapy (ACGT), Sidi Chen, PhD, assistant professor in the Department of Genetics and Systems Biology Institute at Yale School of Medicine and member of Yale Cancer Center,
Read MoreJun 15, 2020
Participants Can Walk, Run, Swim, Bike, Workout, Volunteer to Raise $$$ To Fight Cancer
STAMFORD, Conn. — In recognition of these challenging times and the need to keep swimmers, volunteers, boaters and supporters safe due to COVID-19, Swim Across America Fairfield County has pivoted to a virtual fundraising event —
Read MoreFeb 03, 2020
Novel Gene Therapy Approach to Prostate Cancer Already Seeing Results in Clinical Trial and May Have Impact on Other Solid Tumor Cancers
STAMFORD, Conn. — A scientific team is developing a new CAR T-cell gene therapy treatment for advanced metastatic prostate cancer at the Abramson Cancer Center of the University of Pennsylvania (Philadelphia,
Read MoreFeb 03, 2020
Approach will use Genetically Engineered Immune Cells to Attack Pediatric Sarcoma
STAMFORD, Conn. — An innovative approach to tackling the challenges of pediatric sarcomas is being pursued by researchers at St. Jude Children’s Research Hospital (Memphis, Tennessee) with a new grant from Alliance for Cancer Gene Therapy (ACGT).
Read MoreNov 12, 2019
STAMFORD, Conn., Alliance for Cancer Gene Therapy (ACGT), the nation’s only nonprofit organization dedicated exclusively to funding cancer cell and gene therapy research, announced the availability of grants up to $500,000 each for the 2020 grant cycle. The 2020 awards will focus on research in solid tumors – with a preference for applications in glioblastoma and pancreatic cancer.
Read More